DS Healthcare Group Files U.S. Patent on New Compound for Hair Loss

DS Healthcare Group,Inc.

Pompano Beach, Fla., May 8, 2014 (GLOBE NEWSWIRE) -- DS Healthcare Group, Inc. (NASDAQ: DSKX), a leading developer of personal care products, today announced it has filed its second patent with the U.S. Patent and Trademark Office. This new patent addresses the composition and methods of a new compound described as a calcium-activated potassium channel opening agent for topical treatment of hair loss. DS Healthcare had filed its first patent in October 2013 for its prescription hair loss product currently under development.

We believe this newly filed patent-pending molecule offers a more effective over-the-counter hair loss solution than FDA approved topical minoxidil for hair regrowth. DS Healthcare's proprietary hair loss formulations are a tremendous asset and we are building our IP portfolio including patents, as well as trademarks for our industry-leading brands. While sales of our over-the-counter products continue to grow driven by strong consumer demand, in parallel we are developing our first prescription hair loss product," stated DS Healthcare President and CEO Daniel Khesin.

About DS Healthcare Group

DS Healthcare Group Inc. leads in the development of biotechnology for topical therapies. It markets through online and specialty retailers, distributors, cosmetics wholesalers, and salons. Its research has led to a highly innovative portfolio of personal care products and additional innovations in pharmaceutical projects. For more information on DS Health Group's flagship brand, visit www.dslaboratories.com

Forward-looking statements

Except for statements of historical fact, the matters discussed in this press release are forward-looking and made pursuant to the Safe Harbor provisions of the Private Securities Litigation Reform Act of 1995. "Forward-looking statements" describe future expectations, plans, results, or strategies, and are generally preceded by words such as "future," "plan" or "planned," "expects," or "projected." These forward-looking statements reflect numerous assumptions and involve a variety of risks and uncertainties, many of which are beyond the company's control that may cause actual results to differ materially from stated expectations. These risk factors include, among others, limited operating history, difficulty in developing and marketing products, intense competition, and additional risks factors as discussed in reports filed by the company with the Securities and Exchange Commission, which are available at http://www.sec.gov.

CONTACT: Laurel Moody Corporate Profile 1.646.810.0608

Source:DS Healthcare Group,Inc.